MedTrace Logo

Maternal Serum Amyloid A Levels in Pregnancies Complicated With Preterm Labour.

NCT03205020 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 58

Last updated 2017-07-05

No results posted yet for this study

Summary

The aim of the current study is to assess the accuracy of maternal serum amyloid A for prediction of preterm labor in women with threatened preterm labor.

Conditions

  • Preterm Labor

Interventions

DIAGNOSTIC_TEST

serum amyloid a test

* Women who are diagnosed with preterm labor (28-36 weeks) will be enrolled in this study. Serum samples will be collected from all women before any intervention. All women will be sampled once at the time of admission. * Venous blood sample (5 c.c) will be taken from each participant for examination of serum amyloid A. * The collected blood will be centrifuging and serum will be stored to measure the level of amyloid A by (ELISA) technique in clinical pathology department- Ain shams University

Sponsors & Collaborators

  • mona nematallah

    lead OTHER

Principal Investigators

  • mona mohamed, MS · Ain Shams University

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2018-01-01
Completion
2018-02-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03205020 on ClinicalTrials.gov